Jupiter Endovascular, an endovascular interventions developer, has appointed interventional cardiologist Dr. Catalin Toma as chief medical officer, a new role for the company. Toma brings clinical and research experience across the structural heart and interventional landscape to his new role with Jupiter Endovascular, the company said … [Read more...] about Jupiter Endovascular appoints Catalin Toma as chief medical officer
Jupiter Endovascular
Jupiter Endovascular completes enrollment in Vertex pulmonary embolectomy trial
Jupiter Endovascular announced today that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system. SPIRARE II evaluates the Vertex pulmonary embolectomy system in patients with acute, intermediate-risk pulmonary embolism (PE). Dr. Vikas Aggarwal, interventional cardiologist at Henry Ford Hospital and … [Read more...] about Jupiter Endovascular completes enrollment in Vertex pulmonary embolectomy trial
Jupiter Endovascular reports positive first-in-human pulmonary embolectomy system findings
Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy system. SPIRARE I evaluates the Vertex system featuring transforming fixation (TFX) technology in patients with acute, intermediate-risk pulmonary embolism (PE). Vertex incorporates Jupiter’s novel technology into an endovascular … [Read more...] about Jupiter Endovascular reports positive first-in-human pulmonary embolectomy system findings
Jupiter Endovascular raises more than $40M in oversubscribed Series B
Jupiter Endovascular announced today that it closed an oversubscribed Series B financing that surpassed its target of $40 million. Sonder Capital led the financing, while Senvest Management, LB Investment and a new strategic corporate investor participated. Menlo Park, California-plans to use proceeds to complete its ongoing SPIRARE II pivotal … [Read more...] about Jupiter Endovascular raises more than $40M in oversubscribed Series B
Jupiter Endovascular wins FDA clearance for Vertex catheter
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular devices. According to the FDA 510(k) database, the agency received Jupiter Endovascular's submission on June 30. It delivered the clearance on Sept. 12. The company took to LinkedIn to announce the regulatory … [Read more...] about Jupiter Endovascular wins FDA clearance for Vertex catheter
Jupiter Endovascular reports first patient treated in U.S. study of Vertex pulmonary embolectomy system
Jupiter Endovascular today announced the first U.S. patient treated in its SPIRARE II U.S. pivotal study for the Vertex system. The first U.S. patient treated follows last month's announcement of the first Vertex use in the SPIRARE I study in Poland. SPIRARE II evaluates the Vertex pulmonary embolectomy system in the treatment of acute pulmonary … [Read more...] about Jupiter Endovascular reports first patient treated in U.S. study of Vertex pulmonary embolectomy system
Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
Jupiter Endovascular today announced the first two patients treated in a study of its Vertex pulmonary embolectomy system. Investigators treated two patients in the SPIRARE I study of the Vertex system using the company's Endoportal Control platform technology. Dr. Grzegorz Kopec, Dr. Jakub Stepniewski, and Dr. Krzysztof Bartus performed the … [Read more...] about Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
FDA grants IDE for Jupiter Endovascular’s pulmonary embolectomy system
Jupiter Endovascular announced today that the FDA approved an investigational device exemption (IDE) study for its Vertex system. The company can now conduct the SPIRARE II U.S. pivotal study for the pulmonary embolectomy system. Menlo Park, California-based Jupiter Endovascular only just came out of stealth mode, spinning out of Neptune Medical … [Read more...] about FDA grants IDE for Jupiter Endovascular’s pulmonary embolectomy system
